Greetings from OncoStem ! We are glad you landed on our page. Who are we ? Cancer is a complex disease, and we at OncoStem develop tests that help to identify patterns of cancer recurrence risk. An understanding of these patterns ensures that patients receive personalized therapies and treatments that are best suited to their condition. Founded in 2011, OncoStem aims to develop innovative tests to personalize treatment for cancer patients. Understanding of tumor biology aids physicians in optimizing therapy for cancer patients. Our flagship product CanAssist Breast has been launched for hormone-positive breast cancer. Currently, we are working on similar tests for other cancer types including triple-negative breast cancer and ovarian cancer. Research is underway towards identifying and characterizing novel drug targets for breast and ovarian cancer. We would love to connect with you :)